These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 70974)

  • 1. Purification of Clostridium toxoids.
    Buchowicz I; Hay M; Schiller B; Korbecki M; Sochańska R
    Acta Microbiol Pol; 1977; 26(3):285-94. PubMed ID: 70974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Purification of the toxoids of Cl. Perfringens and Cl. pedematiens using silicagel].
    Efimova NP; Tul'bovich EV
    Zh Mikrobiol Epidemiol Immunobiol; 1977; (1):82-6. PubMed ID: 190831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Clostridium toxoids, especially of Clostridium perfringens toxoid, on mouse transplanted tumors.
    Sasaki T; Chihara G; Takasuka N; Suzuki S
    Gan; 1976 Apr; 67(2):275-7. PubMed ID: 184006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Separation and purification of isoenzymes of Clostridium perfringens phospholipase C].
    Shemanova GF; Dmitrieva LN; Litvinko NM; Firsaeva TM; Buianova NV
    Prikl Biokhim Mikrobiol; 1978; 14(3):399-404. PubMed ID: 209439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Purification and characterization of "Clostridium perfringens" BP6K-N5 strain bacteriocin N5 (author's transl)].
    Wolff A; Ionesco H
    Ann Microbiol (Paris); 1975; 126(3):343-56. PubMed ID: 174471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification and characterization of alpha-toxin of Clostridium oedematiens type A.
    Izumi N; Kondo H; Ohishi I; Sakaguchi G
    Jpn J Med Sci Biol; 1983 Jun; 36(3):135-46. PubMed ID: 6632349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha toxoid of Clostridium perfringens. I. Purification and toxoiding of alpha toxin of C. perfringens.
    Ito A
    Jpn J Med Sci Biol; 1968 Dec; 21(6):379-91. PubMed ID: 4306752
    [No Abstract]   [Full Text] [Related]  

  • 8. [Homogeneous Cl. perfringens alpha-anatoxin: its physicochemical and immunogenic properties].
    Shemanova GF; Petrov RV; Dmitrieva LN; Panteleev EI; Drachev VA
    Zh Mikrobiol Epidemiol Immunobiol; 1978 May; (5):117-22. PubMed ID: 208330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunogenicity and thymus-dependence of the polymerized alpha-toxoid of Clostridium perfringens].
    Petrov RV; Shemanova GF; Kaverzneva ED; Kissel' VL; Panteleev EI
    Biull Eksp Biol Med; 1977 Dec; 84(12):695-8. PubMed ID: 202354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of highly purified -toxoid of Clostridium perfringens.
    Sato H; Kameyama S; Murata R
    Jpn J Med Sci Biol; 1972 Feb; 25(1):53-6. PubMed ID: 4338981
    [No Abstract]   [Full Text] [Related]  

  • 11. [Purification and some properties of "Clostridium perfringens" delta toxin (author's transl)].
    Tixier G; Alouf JE
    Ann Microbiol (Paris); 1976; 127B(4):509-24. PubMed ID: 192118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Physico-chemical and immunobiological properties of the ribosomal preparations of Clostridium perfringens, type A].
    Efimova MG
    Zh Mikrobiol Epidemiol Immunobiol; 1998; (2):46-9. PubMed ID: 9662798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The partial purification of Clostridium perfringens beta toxin.
    Worthington RW; Mülders MS
    Onderstepoort J Vet Res; 1975 Sep; 42(3):91-8. PubMed ID: 172828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Toxoids of botulinum toxin type G].
    Puig de Centorbi ON; Ciccarelli AS; Giménez DF
    Rev Argent Microbiol; 1980; 12(1):10-7. PubMed ID: 6755549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
    Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
    Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The isolation and properties of Clostridium perfringens collagenase].
    Levdikova GA
    Biokhimiia; 1966; 31(4):821-30. PubMed ID: 4299366
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
    Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation to Clostridium septicum toxoid.
    Kennedy K
    Dev Biol Stand; 1976; 32():123-30. PubMed ID: 1001826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The standardization of Cl. perfringens antigens and antisera.
    Jansen BC
    Dev Biol Stand; 1976; 32():35-44. PubMed ID: 187510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and properties of spore-lytic enzymes from Clostridium perfringens type A spores.
    Gombas DE; Labbe RG
    J Gen Microbiol; 1985 Jun; 131(6):1487-96. PubMed ID: 2864386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.